FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3157030630> ?p ?o ?g. }

• W3157030630 endingPage "68" @default.
• W3157030630 startingPage "61" @default.
• W3157030630 abstract "Topical medications are used to treat not only limited, but also common forms of the disease. Currently prescribed external anti-inflammatory drugs have a low selectivity of action, which does not allow achieving a long-term and pronounced clinical effect without the development of undesirable phenomena.&#x0D; This review presents new options for the use of methotrexate in modern topical forms (AuNPs-3MPS), which make it possible to reduce the incidence of adverse events with a high efficiency of therapy. Shown is an innovative drug that blocks resident memory cells (PAP-1), which will influence the course and relapses of the disease, and possibly even lead to the cure of the patient from psoriasis. A new direction has been described inhibition of serine proteases (ER143, AAN-16) and thus inhibition of IL-36-mediated inflammation, which will allow controlling the inflammatory process in psoriasis in the early stages of its development. In addition, a number of drugs are shown whose action is based on blocking intracellular signaling pathways, which leads to inhibition of the development of the inflammatory response and resolution of psoriatic eruptions: inhibitors of Janus kinases (tofacitinib), transcription factor Stat3 (rS3-PA), secondary messenger of signals (SIS3), phosphodiesterase 7 (ASB16165) and 4 (AN-2728/crisaborol), ROR transcription factor (PF-06763809), phospholipase A2 (AVX001), hydrolases (DZ2002).&#x0D; The results of preclinical and initial stages of clinical trials with an assessment of the safety and tolerability of the studied substances are presented. Based on the review, the advantages and disadvantages of the proposed drugs are characterized. Topical therapy with a selective effect on the key links in the development of psoriasis will increase the effectiveness of treatment and reduce the frequency of unwanted effects." @default.
• W3157030630 created "2021-05-10" @default.
• W3157030630 creator A5055408712 @default.
• W3157030630 creator A5057948194 @default.
• W3157030630 creator A5067647199 @default.
• W3157030630 creator A5069156171 @default.
• W3157030630 creator A5078447833 @default.
• W3157030630 creator A5087897904 @default.
• W3157030630 date "2021-04-28" @default.
• W3157030630 modified "2023-10-03" @default.
• W3157030630 title "Perspective trends of topical therapy of patients with psoriasis" @default.
• W3157030630 cites W2001580800 @default.
• W3157030630 cites W2048737912 @default.
• W3157030630 cites W2091996188 @default.
• W3157030630 cites W2157940881 @default.
• W3157030630 cites W2313951506 @default.
• W3157030630 cites W2529788651 @default.
• W3157030630 cites W2575934766 @default.
• W3157030630 cites W2589475182 @default.
• W3157030630 cites W2768115822 @default.
• W3157030630 cites W2790468558 @default.
• W3157030630 cites W2914029499 @default.
• W3157030630 cites W2953457259 @default.
• W3157030630 cites W2969149382 @default.
• W3157030630 cites W2980626371 @default.
• W3157030630 cites W3002649754 @default.
• W3157030630 cites W3002947023 @default.
• W3157030630 cites W3016647913 @default.
• W3157030630 cites W3046561299 @default.
• W3157030630 cites W3048160446 @default.
• W3157030630 cites W3082875048 @default.
• W3157030630 cites W4247665995 @default.
• W3157030630 doi "https://doi.org/10.25208/vdv1212" @default.
• W3157030630 hasPublicationYear "2021" @default.
• W3157030630 type Work @default.
• W3157030630 sameAs 3157030630 @default.
• W3157030630 citedByCount "0" @default.
• W3157030630 crossrefType "journal-article" @default.
• W3157030630 hasAuthorship W3157030630A5055408712 @default.
• W3157030630 hasAuthorship W3157030630A5057948194 @default.
• W3157030630 hasAuthorship W3157030630A5067647199 @default.
• W3157030630 hasAuthorship W3157030630A5069156171 @default.
• W3157030630 hasAuthorship W3157030630A5078447833 @default.
• W3157030630 hasAuthorship W3157030630A5087897904 @default.
• W3157030630 hasBestOaLocation W31570306301 @default.
• W3157030630 hasConcept C112392421 @default.
• W3157030630 hasConcept C126322002 @default.
• W3157030630 hasConcept C16005928 @default.
• W3157030630 hasConcept C197934379 @default.
• W3157030630 hasConcept C203014093 @default.
• W3157030630 hasConcept C2777575956 @default.
• W3157030630 hasConcept C2778375690 @default.
• W3157030630 hasConcept C2778690821 @default.
• W3157030630 hasConcept C2778886723 @default.
• W3157030630 hasConcept C2779134260 @default.
• W3157030630 hasConcept C2780035454 @default.
• W3157030630 hasConcept C2780564577 @default.
• W3157030630 hasConcept C2781059491 @default.
• W3157030630 hasConcept C60644358 @default.
• W3157030630 hasConcept C71924100 @default.
• W3157030630 hasConcept C86803240 @default.
• W3157030630 hasConcept C98274493 @default.
• W3157030630 hasConceptScore W3157030630C112392421 @default.
• W3157030630 hasConceptScore W3157030630C126322002 @default.
• W3157030630 hasConceptScore W3157030630C16005928 @default.
• W3157030630 hasConceptScore W3157030630C197934379 @default.
• W3157030630 hasConceptScore W3157030630C203014093 @default.
• W3157030630 hasConceptScore W3157030630C2777575956 @default.
• W3157030630 hasConceptScore W3157030630C2778375690 @default.
• W3157030630 hasConceptScore W3157030630C2778690821 @default.
• W3157030630 hasConceptScore W3157030630C2778886723 @default.
• W3157030630 hasConceptScore W3157030630C2779134260 @default.
• W3157030630 hasConceptScore W3157030630C2780035454 @default.
• W3157030630 hasConceptScore W3157030630C2780564577 @default.
• W3157030630 hasConceptScore W3157030630C2781059491 @default.
• W3157030630 hasConceptScore W3157030630C60644358 @default.
• W3157030630 hasConceptScore W3157030630C71924100 @default.
• W3157030630 hasConceptScore W3157030630C86803240 @default.
• W3157030630 hasConceptScore W3157030630C98274493 @default.
• W3157030630 hasIssue "2" @default.
• W3157030630 hasLocation W31570306301 @default.
• W3157030630 hasLocation W31570306302 @default.
• W3157030630 hasOpenAccess W3157030630 @default.
• W3157030630 hasPrimaryLocation W31570306301 @default.
• W3157030630 hasRelatedWork W1705742893 @default.
• W3157030630 hasRelatedWork W2000659631 @default.
• W3157030630 hasRelatedWork W2048813874 @default.
• W3157030630 hasRelatedWork W2069013321 @default.
• W3157030630 hasRelatedWork W2164486346 @default.
• W3157030630 hasRelatedWork W2264770719 @default.
• W3157030630 hasRelatedWork W2315667103 @default.
• W3157030630 hasRelatedWork W2963043097 @default.
• W3157030630 hasRelatedWork W3130719820 @default.
• W3157030630 hasRelatedWork W4256085234 @default.
• W3157030630 hasVolume "97" @default.
• W3157030630 isParatext "false" @default.
• W3157030630 isRetracted "false" @default.
• W3157030630 magId "3157030630" @default.

• next